INDIUM IN-111 PENTETREOTIDE
UNII M312JJ6Z32

Substance Identification & Data

This profile provides standardized clinical and technical data for Indium In-111 Pentetreotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M312JJ6Z32.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 139096-04-1 and the RxNorm Concept ID (RxCUI) 1724429. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

M312JJ6Z32

CAS Registry Number

139096-04-1

RxNorm Concept ID

1724429

Detailed Substance Profile

Preferred Name

INDIUM IN-111 PENTETREOTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

M312JJ6Z32

The specific atomic composition represented as a molecular structure string.

InChIKey

C63H83N13O19S2.In.H

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ONJXCGCIKIYAPL-KUUVKUFMSA-K

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1672

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

72127

Unique identification number in the NCBI database of chemical substances.

USAN ID

HH-17

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[H+].[In+3].c1(c2c(cccc2)[nH]c1)C[C@H]3NC(=O)[C@H](Cc4ccccc4)NC([C@@H](NC([C@H](NC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)CC([O-])=O)Cc5ccccc5)=O)CSSC[C@@H](C(N[C@@H]([C@H](O)C)CO)=O)NC(=O)[C@@](NC(=O)[C@H](CCCCN)NC3=O)([C@@H](C)O)[H])=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Indium In-111 Pentetreotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.